EP Patent

EP0535327A1 — Pharmaceutical composition containing felbinac

Assigned to Wyeth Holdings LLC · Expires 1993-04-07 · 33y expired

What this patent protects

A pharmaceutical composition for topical application comprises 4-biphenylacetic acid (BPAA) or a pharmaceutically acceptable salt or ester thereof in a carrier which is adapted to form a quick-breaking foam, the composition being maintained under pressure. The composition can be …

USPTO Abstract

A pharmaceutical composition for topical application comprises 4-biphenylacetic acid (BPAA) or a pharmaceutically acceptable salt or ester thereof in a carrier which is adapted to form a quick-breaking foam, the composition being maintained under pressure. The composition can be applied topically for the rapid relief of painful inflammation.

Drugs covered by this patent

Patent Metadata

Patent number
EP0535327A1
Jurisdiction
EP
Classification
—
Expires
1993-04-07
Drug substance claim
No
Drug product claim
No
Assignee
Wyeth Holdings LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.